Ubrogepant is indicated for the acute (immediate) treatment of migraine with or without aura (a sensory phenomenon or visual disturbance) in adults. It was approved by the FDA on December 23, 2019.
Synonyms: Ubrogepantum Ubrogepant Ubrogépant
This is just here as a test because I lose it
Term information
database
cross reference
- CAS:1374248-77-7
- ChemSpider:28536135
- ChEMBL:CHEMBL2364638
- Wikipedia:Ubrogepant